Ophthalmology News

Unexplained mydriasis with cycloplegia in children and teens can cause great parental concern, especially if the patient reports an inability to do schoolwork.

It is autumn on the North Coast. Longer nights lead to deeper insights as we contemplate the winter solstice. As usual, I am thinking dry eye. It is, as they say, how I roll.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Douglas Love, president and CEO of Annexon Biosciences, discusses the company’s phase 3 program in geographic atrophy.

Nonqualified plans offer a valuable alternative or supplement to qualified retirement plans for physicians seeking to enhance their retirement savings.

CHICAGO — Many diseases can present as dry eye, leading to missed diagnoses and failed treatment, according to a speaker here.

In this video, Barbara Blodi, MD, discusses results from the ARCHER trial presented at the American Society of Retina Specialists annual meeting.

CHICAGO — In this Healio Video Perspective from the AAO meeting, William B. Trattler, MD, discusses a study that evaluated age and keratoconus progression.

Okyo Pharma has announced that screening and recruitment has been initiated for a phase 2 trial of OK-101 to treat neuropathic corneal pain, with plans to enroll 48 patients, according to a company press release.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Lisa K. Feulner, MD, PhD, explains why surgeons must treat the ocular surface before refractive cataract surgery and shares her algorithm for management.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Allen C. Ho, MD, of Wills Eye Hospital shares promising results of a phase 2b/3 trial investigating MCO-010 optogenetic therapy for the treatment of retinitis pigmentosa.